Armistice Capital, Llc Onconova Therapeutics, Inc. (ONTX) insider trading activity

Armistice Capital, LLC is > 10% Shareholder of Onconova Therapeutics, Inc.. Currently has a direct ownership of 816,702 shares of ONTX, which is worth approximately $481,854. The most recent transaction as insider was on Sep 23, 2019, when has been sold 10,249 shares (Common Stock) at a price of $1.27 per share, resulting in proceeds of $13,016. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 817K

0% 3M change

0% 12M change

Total Value Held $481,854

ARMISTICE CAPITAL, LLC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Sep 23 2019	SELL Open market or private sale	$13,016 $1.27 p/Share	10,249 Reduced 1.24%	816,702 Common Stock

Also insider at

SAVA

CASSAVA SCIENCES INC Healthcare

> 10% Shareholder

VXRT

Vaxart, Inc. Healthcare

Director

AVTX

Avalo Therapeutics, Inc. Healthcare

> 10% Shareholder

ACHV

ACHIEVE LIFE SCIENCES, INC. Healthcare

> 10% Shareholder

ALIM

ALIMERA SCIENCES INC Healthcare

> 10% Shareholder

BPTH

BIO-PATH HOLDINGS INC Healthcare

> 10% Shareholder

AYTU

AYTU BIOPHARMA, INC Healthcare

Director

CYTH

Cyclo Therapeutics, Inc. Healthcare

> 10% Shareholder

BBI

Brickell Biotech, Inc. Healthcare

> 10% Shareholder

RSLS

ReShape Lifesciences Inc. Healthcare

> 10% Shareholder

TENX

TENAX THERAPEUTICS, INC. Healthcare

Director

KPRX

KIORA PHARMACEUTICALS INC Healthcare

> 10% Shareholder

TTPH

TETRAPHASE PHARMACEUTICALS INC

Director

AMAG

AMAG PHARMACEUTICALS, INC.

> 10% Shareholder

VLRX

Valeritas Holdings Inc.

> 10% Shareholder

DFRG

Del Frisco's Restaurant Group, Inc.

> 10% Shareholder

RSLS

ReShape Weightloss Inc.

> 10% Shareholder

INNV

INNOVUS PHARMACEUTICALS, INC.

> 10% Shareholder

ACL